Matthew Foote

4.0k total citations
131 papers, 2.4k citations indexed

About

Matthew Foote is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Matthew Foote has authored 131 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pulmonary and Respiratory Medicine, 44 papers in Oncology and 40 papers in Surgery. Recurrent topics in Matthew Foote's work include Brain Metastases and Treatment (41 papers), Glioma Diagnosis and Treatment (30 papers) and Management of metastatic bone disease (30 papers). Matthew Foote is often cited by papers focused on Brain Metastases and Treatment (41 papers), Glioma Diagnosis and Treatment (30 papers) and Management of metastatic bone disease (30 papers). Matthew Foote collaborates with scholars based in Australia, United States and Canada. Matthew Foote's co-authors include Arjun Sahgal, Tarl W. Prow, Miko Yamada, Bryan Burmeister, Michael Poulsen, Sandro Porceddu, Michael Veness, Kristin J. Redmond, D. Létourneau and Mark B. Pinkham and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Biochemistry and Journal of neurosurgery.

In The Last Decade

Matthew Foote

128 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Foote Australia 28 859 785 608 370 370 131 2.4k
Mark N. Gaze United Kingdom 31 753 0.9× 912 1.2× 735 1.2× 258 0.7× 546 1.5× 166 3.1k
Steve P. Lee United States 30 844 1.0× 703 0.9× 997 1.6× 383 1.0× 281 0.8× 73 2.7k
Stefano Pergolizzi Italy 26 581 0.7× 637 0.8× 865 1.4× 314 0.8× 513 1.4× 146 2.2k
Usama Mahmood United States 30 942 1.1× 552 0.7× 1.1k 1.9× 448 1.2× 486 1.3× 72 2.8k
Maurizio Amichetti Italy 31 728 0.8× 874 1.1× 1.1k 1.7× 556 1.5× 632 1.7× 136 3.1k
Stefano Maria Magrini Italy 27 748 0.9× 555 0.7× 1.4k 2.3× 356 1.0× 468 1.3× 163 2.7k
Sunil Gulavita Canada 14 771 0.9× 465 0.6× 1.0k 1.7× 578 1.6× 555 1.5× 20 2.8k
Simone Marnitz Germany 28 965 1.1× 806 1.0× 951 1.6× 407 1.1× 865 2.3× 141 3.3k
M. Balducci Italy 25 828 1.0× 610 0.8× 993 1.6× 458 1.2× 598 1.6× 133 2.4k
Charles W. Scarantino United States 21 664 0.8× 810 1.0× 858 1.4× 443 1.2× 422 1.1× 62 2.1k

Countries citing papers authored by Matthew Foote

Since Specialization
Citations

This map shows the geographic impact of Matthew Foote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Foote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Foote more than expected).

Fields of papers citing papers by Matthew Foote

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Foote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Foote. The network helps show where Matthew Foote may publish in the future.

Co-authorship network of co-authors of Matthew Foote

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Foote. A scholar is included among the top collaborators of Matthew Foote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Foote. Matthew Foote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hong, Angela, Serigne Lo, Gerald B. Fogarty, et al.. (2024). A randomised, controlled, multicentre trial of imiquimod versus radiotherapy for lentigo maligna.. Journal of Clinical Oncology. 42(16_suppl). 9502–9502. 5 indexed citations
2.
Pinkham, Mark B., et al.. (2024). Patient reported outcomes and short-term adjustment trajectories following gamma knife radiosurgery for benign brain tumor. Disability and Rehabilitation. 47(11). 2799–2808. 1 indexed citations
3.
Azadbakht, Javid, Wende N. Gibbs, Pejman Maralani, et al.. (2024). The Role of CT and MR Imaging in Stereotactic Body Radiotherapy of the Spine: From Patient Selection and Treatment Planning to Post-Treatment Monitoring. Cancers. 16(21). 3692–3692. 1 indexed citations
4.
Pinkham, Mark B., Katarzyna Lion, Matthew Foote, et al.. (2023). Individuals’ perceptions of health and well-being in the context of stereotactic radiosurgery for benign brain tumour: A longitudinal qualitative investigation. Neuropsychological Rehabilitation. 34(2). 244–267. 1 indexed citations
5.
Ownsworth, Tamara, et al.. (2022). “Hey, I’m still here!”: Maintaining, managing and rebuilding social connections after brain tumour. Neuropsychological Rehabilitation. 33(3). 454–479. 9 indexed citations
6.
Shanker, Mihir, Victoria Atkinson, Wen Xu, et al.. (2022). Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes. Journal of Medical Imaging and Radiation Oncology. 66(4). 536–545. 8 indexed citations
7.
Chen, Hanbo, Serena Badellino, Tithi Biswas, et al.. (2022). Conditional Survival of Patients With Extracranial Oligometastatic Treated With Stereotactic Body Radiation Therapy: An International Consortium Study. International Journal of Radiation Oncology*Biology*Physics. 114(5). 902–909. 3 indexed citations
8.
Chen, Hanbo, Ian Poon, Eshetu G. Atenafu, et al.. (2021). Development of a Prognostic Model for Overall Survival in Patients With Extracranial Oligometastatic Disease Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 114(5). 892–901. 7 indexed citations
9.
Chen, Hanbo, Arjun Sahgal, Darby Erler, et al.. (2021). Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease. Cancer Medicine. 10(22). 8091–8099. 5 indexed citations
10.
Chen, Xuguang, Hanbo Chen, Ian Poon, et al.. (2021). Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis. Cancer Medicine. 10(18). 6189–6198. 7 indexed citations
11.
Pinkham, Mark B., et al.. (2020). Leksell Gamma Knife® – The first 1000 patients from the radiation therapist’s perspective. Journal of Medical Radiation Sciences. 68(3). 320–325. 1 indexed citations
12.
13.
Schaub, Stephanie K., Yolanda D. Tseng, Eric L. Chang, et al.. (2019). Strategies to Mitigate Toxicities From Stereotactic Body Radiation Therapy for Spine Metastases. Neurosurgery. 85(6). 729–740. 11 indexed citations
14.
Khasraw, Mustafa, Kerrie L. McDonald, Mark Rosenthal, et al.. (2019). A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY. Neuro-Oncology. 21. 18–18. 1 indexed citations
15.
Joseph, Shannon R., Rachael Barry, Blerida Banushi, et al.. (2018). An Ex Vivo Human Tumor Assay Shows Distinct Patterns of EGFR Trafficking in Squamous Cell Carcinoma Correlating to Therapeutic Outcomes. Journal of Investigative Dermatology. 139(1). 213–223. 17 indexed citations
16.
Chang, Joe H., Senthilkumar Gandhidasan, Alan Herschtal, et al.. (2017). Stereotactic Ablative Body Radiotherapy for the Treatment of Spinal Oligometastases. Clinical Oncology. 29(7). e119–e125. 32 indexed citations
17.
Harden, Fiona, et al.. (2015). Sensorineural Hearing Loss: Who Is Most At Risk?. Asia-Pacific Journal of Clinical Oncology. 11. 130–131. 1 indexed citations
18.
Harden, Fiona, et al.. (2014). Sensorineural hearing loss after treatment for head and neck cancer: A review of the literature. QUT ePrints (Queensland University of Technology). 6 indexed citations
19.
Foote, Matthew. (2012). The development of advanced radiotherapy treatment techniques. Queensland's institutional digital repository (The University of Queensland). 36(2). 74–77. 1 indexed citations
20.
Barry, Rachael, Duncan Lambie, Sandro Porceddu, et al.. (2011). Estimation of EGF receptor expression and trafficking dysregulation in live tissue samples of cutaneous SCC and precursor lesions. Australasian Journal of Dermatology. 52. 11–11. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark N. Gaze Breakdown of academic impact, for papers by Steve P. Lee Breakdown of academic impact, for papers by Stefano Pergolizzi Breakdown of academic impact, for papers by Usama Mahmood Breakdown of academic impact, for papers by Maurizio Amichetti Breakdown of academic impact, for papers by Stefano Maria Magrini Breakdown of academic impact, for papers by Sunil Gulavita Breakdown of academic impact, for papers by Simone Marnitz Breakdown of academic impact, for papers by M. Balducci Breakdown of academic impact, for papers by Charles W. Scarantino
Rankless by CCL
2026